Ann: Trading Halt, page-845

You pick apart information and put them in different post to confuse. Very well, lets play your game.

> Cash outflows in the two reported quarters since that A$75m raising amounted to US$43m (around A$68m), so most of the $75m

MSB had cash of US$ 34.5 million by of by the end of Sept 2019. They raised additional cash of US$50,6 million (AUD$75 million) to "principally" build inventory and a targeted US sales force. They also said that the fund will be used to finish phase 3 heart and lower back pain. This leaves MSB with US$ 81.3 million cash by 31 Dec 2019. Last quarterly reported US$ 60 million by 31 March 2020. By this time, heart and lower back pain are all completed. Note that half of operating cash outflow are for R&D. This component should significantly reduce in the future. The future look bright.